A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin

Clinical trial NCT00268853 · COMPLETED

Trial details

NCT number: NCT00268853
Sponsor: CTI BioPharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Large-Cell Lymphoma

Start date: 2005-11-01
Primary completion: 2012-05-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.